Emerging & Established Markets, Declining R&D Productivity, Cost-Effective Healthcare Provision – Opportunity to Create an Integrated New World Health Order

Mian Atif Saeed

Abstract

Emerging markets are now the focal point of pharmaceutical industry. Stagnant growth in western established markets coupled with increasing pressure on pricing and difficulties in market access is forcing the industry to focus on emerging markets. In order to make this shift productive for overall global healthcare environment, the industry needs to work towards strategies whereby these emerging markets are not looked in isolation as mere additional revenue generating markets but are instead made partners in overall global strategies – for business and global healthcare. An all encompassing strategic global plan involving emerging markets is the need of the day. This will not only help improve the overall financial figures for the industry and operational streamlining but will but will also offer to a way forward whereby a true global policy and system is put in place to address cost-effective global healthcare provision issue to improve and safe lives.